FDA approves Epidiolex derived from marijuana, for severe epilepsy
28 June 2018 | By European Pharmaceutical Review
The FDA has approved Epidiolex oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy...
List view / Grid view
Medical Marijuana
Hemp shows potential for treating ovarian cancer
24 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers demonstrate hemp's ability to slow cancer growth and uncover mechanism for its cancer-fighting ability...
First-in-Human trial of cannabis-based therapy for Parkinson’s initiated
12 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
Cannabinoids suitable for migraine prevention
29 June 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A study has confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.
Follow: